Entrada Therapeutics (TRDA) Assets: 2022-2025
Historic Assets for Entrada Therapeutics (TRDA) over the last 4 years, with Sep 2025 value amounting to $412.9 million.
- Entrada Therapeutics' Assets fell 25.55% to $412.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $412.9 million, marking a year-over-year decrease of 25.55%. This contributed to the annual value of $526.3 million for FY2024, which is 12.18% up from last year.
- Per Entrada Therapeutics' latest filing, its Assets stood at $412.9 million for Q3 2025, which was down 8.00% from $448.8 million recorded in Q2 2025.
- Over the past 5 years, Entrada Therapeutics' Assets peaked at $582.0 million during Q2 2024, and registered a low of $252.1 million during Q4 2022.
- For the 3-year period, Entrada Therapeutics' Assets averaged around $495.1 million, with its median value being $486.5 million (2025).
- Its Assets has fluctuated over the past 5 years, first skyrocketed by 86.15% in 2023, then dropped by 25.55% in 2025.
- Quarterly analysis of 4 years shows Entrada Therapeutics' Assets stood at $252.1 million in 2022, then spiked by 86.15% to $469.2 million in 2023, then increased by 12.18% to $526.3 million in 2024, then fell by 25.55% to $412.9 million in 2025.
- Its Assets was $412.9 million in Q3 2025, compared to $448.8 million in Q2 2025 and $486.5 million in Q1 2025.